Summary:
We are conducting a safety and efficacy study of inhaled fluticasone propionate/salmeterol combination versus inhaled fluticasone propionate in the treatment of adolescent and adult subjects with Asthma.
Qualified Participants Must:
• Be 12 years of age, or older
•
Have moderate to severe Asthma diagnosed for atleast 1 year
Qualified Participants May Receive:
No cost study related care and medication.
Compensation for time and travel